✦ LIBER ✦
Decreased levels of hypoxic cells in gefitinib treated ER+HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin
✍ Scribed by Wieslawa H. Dragowska; Maïté Verreault; Donald T. T. Yapp; Corinna Warburton; Lincoln Edwards; Euan C. Ramsay; Lynsey A. Huxham; Andrew I. Minchinton; Karen Gelmon; Marcel B. Bally
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 471 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.